Meet the developers behind the Pfizer building conversion
New York City turned its eyes towards the former Pfizer building in Midtown East Tuesday morning, but not for the reason the developers would’ve hoped. Reports emerged before 8 a.m. of debris falling from the construction site at 235 East 42nd Street, arguably the country’s most notable office-to-residential conversion post-pandemic to unfold. As of midday, concerns about the safety of the building remain as columns within the building buckle, forcing evacuations and street closures in and around the property. It’s not the first notable incident at the project, which commanded real estate’s attention long before pedestrians were forced to steer […]
This article originally appeared on The Real Deal. Click here to read the full story.
Categories
Recent Posts

Forecast 2027: Housing Transactions Hold Steady Despite High
Rates

Mortgage Rates Have Jumped And Builders Are Moving To
Adapt

Reality Check: Mamdani’s “transfer” program gets
started

Manhattan office market closing in on pre-Covid
reality

Carnegie House co-op wins new shot in ground lease
fight

NY AG bans Brooklyn developer for six years over misused
buyer funds

Mamdani wants to “recognize” tenant unions. What would that
look like?

NY Dirt: A lead poisoning case, a legal web, and new
ownership in Brooklyn

America’s Top & Best-In-State Residential Architects
2026: Methodology

10 Real Estate Open House Ideas to Make Your Home Stand
Out


